Skip to main content

EU Considers Curbing Antibiotic Use

The European Medicines Agency has recommended that farmers stop using the antibiotic colistin prophylactically, citing human health concerns.

Written byChris Palmer
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00

WIKIMEDIA COMMONS, DOHDUHDAHReflecting growing worries about the overuse of antibiotics contributing to the global public health threat of drug-resistant bacterial infections in humans, the European Medicines Agency (EMA) has suggested a ban on the blanket use of the antibiotic colistin for farm animals, Nature reported Tuesday (July 30). The agency said that colistin, which has been used by veterinarians for more than 50 years, should still be made available, but that the drug’s use should be restricted to infected animals or animals in contact with infections. The European Commission will soon make a decision about the proposed restriction.

The EMA also indicated that there was no evidence in support of the prophylactic use of another antibiotic called tigecycline, which is not currently approved for use in animals, though the agency fell short of a formal recommendation for guidelines on its use. Both colistin and tigecycline are regularly prescribed in human medicine as life-saving treatments against infections caused by multidrug-resistant bacteria.

“The EMA recommendation is the precautionary approach, and is laudable,” Laura Piddock, a microbiologist at the University of Birmingham in the U.K. and director of Antibiotic Action, which encourages the development of new antibiotics, told Nature. “The reality is that we should question the use of any antibacterial agent outside of human medicine and until there is unequivocal evidence showing no effect of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related Topics

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems
Optimizing NGS Library Preparation for Reliable Sequencing Data

Optimizing NGS Library Preparation for Reliable Sequencing Data

Covaris
Using TCR Repertoire Sequencing to Advance Immunology Research

Using TCR Repertoire Sequencing to Advance Immunology Research

Miltenyi

Products

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo
Conceptual image of ice and frost.

The VAULT100 PRO: Inside the most advanced Stirling Ultracold ULT freezer ever built.

Stirling Ultracold logo